Perioperative sintilimab combination with SOX for resectable locally advanced gastric/gastroesophageal junction cancer(GC/GEJC): Initial findings of a single-arm phase II trial

被引：8
|
作者：
Ding, Xuewei [1 ]
Li, Bin [1 ]
Xue, Qiang [1 ]
Cai, Mingzhi [1 ]
Cui, Jingli [1 ]
Wang, Baogui [1 ]
Ke, Bin [1 ]
Zhang, Rupeng [1 ]
Liang, Han [1 ]
机构：
[1] Tianjin Med Univ, Canc Inst & Hosp, Dept Gastr Surg, Tianjin, Peoples R China
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2022年 / 40卷 / 04期
关键词：
D O I：
10.1200/JCO.2022.40.4_suppl.294
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
294
引用
收藏
页数：3
相关论文
共 50 条
  • [1] PERSIST: A multicenter, randomized phase II trial of perioperative oxaliplatin and S-1 (SOX) with or without sintilimab in resectable locally advanced gastric/gastroesophageal junction cancer (GC/GEJC).
    Ding, Xuewei
    Wang, Xuejun
    Li, Bin
    Wang, Longgang
    Guo, Honghai
    Shang, Liang
    Huang, Wenbai
    Wu, Liangliang
    Ke, Bin
    Liu, Yong
    Liu, Ning
    Wang, Baogui
    Cai, Mingzhi
    Deng, Jingyu
    Zhang, Rupeng
    Zhang, Jiancheng
    Chai, Jie
    Zhao, Qun
    Li, Leping
    Liang, Han
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 : 364 - 364
  • [2] Neoadjuvant sintilimab in combination with concurrent chemoradiotherapy for locally advanced gastric or gastroesophageal junction adenocarcinoma: a single-arm phase 2 trial
    Wei, Jia
    Lu, Xiaofeng
    Liu, Qin
    Fu, Yao
    Liu, Song
    Zhao, Yang
    Zhou, Jiawei
    Chen, Hui
    Wang, Meng
    Li, Lin
    Yang, Ju
    Liu, Fangcen
    Zheng, Liming
    Yin, Haitao
    Yang, Yang
    Zhou, Chong
    Zeng, Ping
    Zhou, Xiaoyu
    Ding, Naiqing
    Chen, Shiqing
    Zhao, Xiaochen
    Yan, Jing
    Fan, Xiangshan
    Guan, Wenxian
    Liu, Baorui
    [J]. NATURE COMMUNICATIONS, 2023, 14 (01)
  • [3] Neoadjuvant sintilimab in combination with concurrent chemoradiotherapy for locally advanced gastric or gastroesophageal junction adenocarcinoma: a single-arm phase 2 trial
    Jia Wei
    Xiaofeng Lu
    Qin Liu
    Yao Fu
    Song Liu
    Yang Zhao
    Jiawei Zhou
    Hui Chen
    Meng Wang
    Lin Li
    Ju Yang
    Fangcen Liu
    Liming Zheng
    Haitao Yin
    Yang Yang
    Chong Zhou
    Ping Zeng
    Xiaoyu Zhou
    Naiqing Ding
    Shiqing Chen
    Xiaochen Zhao
    Jing Yan
    Xiangshan Fan
    Wenxian Guan
    Baorui Liu
    [J]. Nature Communications, 14
  • [4] Fruquintinib combined with sintilimab and SOX as conversion therapy for unresectable locally advanced or metastatic gastric/gastroesophageal junction adenocarcinoma (GC/GEJC): A single-arm, open-label, phase 2 clinical trial.
    Ma, Fei
    Luo, Suxia
    Zhang, Bin
    Ma, Qi
    Ji, Sheqing
    Zhang, Zhandong
    Zhang, Yonglei
    Yang, Wei
    Peng, Liangqun
    Guo, Dandan
    Ren, Jinjun
    Zhang, Yuan
    Su, Yueyue
    Li, Jing
    Liu, Wentao
    Huang, Jinxi
    Yuan, Weiwei
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (16)
  • [5] Surufatinib plus sintilimab in patients with advanced gastric/gastroesophageal junction adenocarcinoma (GC/GEJC): A single-arm, open-label, single-center phase II trial.
    Zhang, Dong-Sheng
    Liu, Fu-Rong
    Lu, Yun-Xin
    Bai, Bing
    Zhang, Yang
    Wang, Zhi-Qiang
    Liu, Yu
    Chen, Jian-Wen
    Wang, Feng
    Xu, Rui-Hua
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (3_SUPPL) : 358 - 358
  • [6] Fruquintinib combined with sintilimab as a second-line therapy for advanced gastric and gastroesophageal junction adenocarcinoma (GC/GEJC): A phase II, single-arm, prospective study.
    Jin, Min
    Yang, Shengli
    Liu, Junli
    Zhang, Jieying
    Zhao, Lei
    Yu, Dandan
    Lin, Zhenyu
    Li, Pindong
    Wang, Jing
    Xue, Jun
    Ma, Hong
    Hu, Jianli
    Zhang, Tao
    Liu, Hongli
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (3_SUPPL) : 332 - 332
  • [7] Perioperative camrelizumab combined with chemotherapy for locally advanced gastric or gastroesophageal junction adenocarcinoma: A single-arm, single-center, phase II clinical trial
    He, J.
    Yang, Y.
    Zhou, S.
    Zhang, B.
    Han, Z.
    Wu, T.
    Qiao, Q.
    Yang, H.
    He, X.
    Wang, N.
    [J]. ANNALS OF ONCOLOGY, 2023, 34 : S1549 - S1549
  • [8] Neoadjuvant sintilimab and apatinib combined with perioperative FLOT chemotherapy for locally advanced gastric cancer: A prospective, single-arm, phase II study
    Zhou Huinian
    Long Bo
    Yu Zeyuan
    Zhu Junmin
    Yang Hanteng
    Luo Changjiang
    Zhang Wenjuan
    Dong Chi
    Guan Xiaoying
    Li Long
    Zhang Gengyuan
    Cao Hongtai
    Chen Shigong
    Zhou Linyan
    He Qichen
    Gan Shiying
    Jiang Xiangyan
    Gu Qianlin
    Wang Keshen
    Shi Wengui
    Qin Long
    Jiao Zuoyi
    [J]. 中华医学杂志英文版., 2024, 137 (21)
  • [9] Perioperative sintilimab in combination with concurrent chemoradiotherapy for patients with locally advanced gastric or gastroesophageal junction (GEJ) adenocarcinoma
    Wei, J.
    Lu, X.
    Liu, Q.
    Li, L.
    Liu, S.
    Liu, F.
    Fu, Y.
    Fan, X.
    Yang, J.
    Yang, Y.
    Zhao, Y.
    Guan, W.
    Liu, B.
    [J]. ANNALS OF ONCOLOGY, 2020, 31 : S1316 - S1316
  • [10] Efficacy and safety of perioperative chemotherapy combined with tislelizumab and trastuzumab for HER2positive resectable gastric/gastroesophageal junction cancer (GC/EGJC): Preliminary results of a phase II, single-arm trial
    Wang, F.
    Zhao, C.
    Xia, J.
    Liu, Z.
    Meng, X.
    Shan, Z.
    Jiang, J.
    Liu, X.
    Li, H.
    Sun, J.
    Ding, C.
    Zhang, H.
    Liang, W.
    [J]. ANNALS OF ONCOLOGY, 2023, 34 : S865 - S865
12345